PaxMedica Inc. Gains 47.54%
Tue, Nov 07, 2023 at 07:09 PM
PaxMedica Inc. (PXMD:NASDAQ) soared at $4.5, representing a gain of 47.5%. On Tue, Nov 07, 2023, PXMD:NASDAQ hit a New 2-Week High of $4.5. The stock appeared on our News Catalysts scanner on Tue, Nov 07, 2023 at 11:28 AM in the 'BIOTECH' category. From Wed, Oct 25, 2023, the stock recorded 55.56% Up Days and 50.00% Green Days
The stock spiked on Tue, Nov 07, 2023 at $10.26 with a volume of 35M+.
About PaxMedica Inc. (PXMD:NASDAQ)
PaxMedica Inc an early clinical stage biopharmaceutical company focusing on the development of anti-purinergic therapies (or APT), for the treatment of neurodevelopmental disorders, including autism...
Top 10 Gainers:
- Tempo Automation Holdings Inc. (TMPO:NASDAQ), 250%
- Cardio Diagnostics Holdings Inc Com (CDIO:NASDAQ), 102.94%
- Senti Biosciences Inc Com (SNTI:NASDAQ), 78.08%
- Jaguar Global Growth Corporation I (JGGC:NASDAQ), 69.64%
- Vinco Ventures Inc. (BBIG:NASDAQ), 66.67%
- Tharimmune Inc Com (THAR:NASDAQ), 64.87%
- Korro Bio, Inc. (KRRO:NASDAQ), 60.81%
- TransMedics Group, Inc. (TMDX:NASDAQ), 51.18%
- PaxMedica Inc. (PXMD:NASDAQ), 47.54%
- Nuburu Inc. (BURU:NYSEMKT), 37.8%